iShares Biotechnology ETF $IBB Shares Sold by Lido Advisors LLC

Lido Advisors LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 62.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,350 shares of the financial services provider’s stock after selling 20,288 shares during the period. Lido Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,086,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Brighton Jones LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at $201,000. AQR Capital Management LLC acquired a new position in iShares Biotechnology ETF during the 1st quarter worth $455,000. Millennium Management LLC grew its stake in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares in the last quarter. M&T Bank Corp increased its holdings in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after purchasing an additional 750 shares during the period. Finally, Walleye Capital LLC raised its position in iShares Biotechnology ETF by 26.8% in the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock valued at $589,000 after purchasing an additional 985 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $188.14 on Monday. iShares Biotechnology ETF has a 1 year low of $130.25 and a 1 year high of $199.05. The stock has a 50-day simple moving average of $179.53 and a 200-day simple moving average of $174.10.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were issued a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a yield of 0.1%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.